OpenURL Connection Search

Select item for more details and to access through your institution.

Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Published in:
1993
By:
- HOUYAU, PHILIPPE;
- GAY, CROISINE;
- CHATELUT, ETIENNE;
- CANAL, PIERRE;
- ROCHÉ, HENRI;
- MILANO, GÉRARD;
- Houyau, P;
- Gay, C;
- Chatelut, E;
- Canal, P;
- Roché, H;
- Milano, G
Publication type:
Case Study
Impact du génotype sur la tolérance à l'irinotécan et au cisplatine.
Published in:
Oncologie (Tech Science Press), 2014, v. 16, n. 2/3, p. 103, doi. 10.1007/s10269-014-2374-2
By:
- Paludetto, M.;
- Chatelut, E.
Publication type:
Article
Les dérivés du platine.
Published in:
Oncologie (Tech Science Press), 2007, v. 9, n. 11, p. 741, doi. 10.1007/s10269-007-0700-7
By:
- Thomas, F.;
- Chatelut, E.
Publication type:
Article
UDP-glucuronosyl-transférase 1A1 et pharmacogénétique de l’irinotécan.
Published in:
Oncologie (Tech Science Press), 2005, v. 7, n. 1, p. 49, doi. 10.1007/s10269-005-0152-x
By:
- Puisset, F.;
- Chatelut, E.
Publication type:
Article
Practical Treatment Guide for Dose Individualisation in Cancer Chemotherapy.
Published in:
Drugs, 1998, v. 56, n. 6, p. 1019, doi. 10.2165/00003495-199856060-00006
By:
- Canal, P.;
- Chatelut, E.;
- Guichard, S.
Publication type:
Article
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.
Published in:
British Journal of Cancer, 2012, v. 107, n. 7, p. 1100, doi. 10.1038/bjc.2012.357
By:
- Chatelut, E;
- White-Koning, M L;
- Mathijssen, R HJ;
- Puisset, F;
- Baker, S D;
- Sparreboom, A
Publication type:
Article
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.
Published in:
2008
By:
- Rouits, E;
- Charasson, V;
- Pétain, A;
- Boisdron-Celle, M;
- Delord, J-P;
- Fonck, M;
- Laurand, A;
- Poirier, A-L;
- Morel, A;
- Chatelut, E;
- Robert, J;
- Gamelin, E;
- Pétain, A
Publication type:
journal article
Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 2, p. 235, doi. 10.1002/cpt.210
By:
- Thomas, F;
- Hennebelle, I;
- Delmas, C;
- Lochon, I;
- Dhelens, C;
- Garnier Tixidre, C;
- Bonadona, A;
- Penel, N;
- Goncalves, A;
- Delord, JP;
- Toulas, C;
- Chatelut, E
Publication type:
Article
The Scientific Basis of Body Surface Area-Based Dosing.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 359, doi. 10.1038/clpt.2014.7
By:
- Chatelut, E;
- Puisset, F
Publication type:
Article
Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in children.
Published in:
European Journal of Clinical Pharmacology, 2001, v. 57, n. 4, p. 297, doi. 10.1007/s002280100306
By:
- Patoux, A.;
- Bleyzac, N.;
- Boddy, A.;
- Doz, F.;
- Rubie, H.;
- Bastian, G.;
- Maire, P.;
- Canal, P.;
- Chatelut, E.
Publication type:
Article
Pharmacokinetics of heated intraperitoneal oxaliplatin.
Published in:
Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 679, doi. 10.1007/s00280-007-0654-x
By:
- Ferron, G.;
- Dattez, S.;
- Gladieff, L.;
- Delord, J.-P.;
- Pierre, S.;
- Lafont, T.;
- Lochon, I.;
- Chatelut, E.
Publication type:
Article
Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study.
Published in:
Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 3, p. 365, doi. 10.1007/s00280-006-0375-6
By:
- Bonneterre, J.;
- Campone, M.;
- Koralewski, P.;
- Blasinska-Morawiec, M.;
- Deporte-Fety, R.;
- Chatelut, E.;
- Leger, F.;
- Longerey, B.;
- Ecochard, L.;
- Douville, I.
Publication type:
Article
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect.
Published in:
Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 305, doi. 10.1007/s00280-006-0385-4
By:
- Puisset, F.;
- Chatelut, E.;
- Sparreboom, A.;
- Delord, J.-P.;
- Berchery, D.;
- Lochon, I.;
- Lafont, T.;
- Roché, H.
Publication type:
Article
Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG.
Published in:
British Journal of Clinical Pharmacology, 2007, v. 63, n. 4, p. 505, doi. 10.1111/j.1365-2125.2007.02886_4.x
By:
- Joerger, M.;
- Huitema, A. D. R.;
- Richel, D. J.;
- Dittrich, C.;
- Pavlidis, N.;
- Briasoulis, E.;
- Vermorken, J. B.;
- Strocchi, E.;
- Martoni, A.;
- Sorio, R.;
- Sleeboom, H. P.;
- Izquierdo, M. A.;
- Jodrell, D. I.;
- Calvert, A. H.;
- Boddy, A.;
- Hollema, H.;
- Féty, R.;
- Van der Vijgh, W. J. F.;
- Hempel, G.;
- Chatelut, E.
Publication type:
Article
Yohimbine increases human salivary secretion.
Published in:
British Journal of Clinical Pharmacology, 1989, v. 28, n. 3, p. 366, doi. 10.1111/j.1365-2125.1989.tb05440.x
By:
- Chatelut, E.;
- Rispail, Y.;
- Berlan, M.;
- Montastruc, JL
Publication type:
Article
Clinical pharmacodynamic factors in docetaxel toxicity.
Published in:
British Journal of Cancer, 2007, v. 97, n. 3, p. 290, doi. 10.1038/sj.bjc.6603872
By:
- Puisset, F.;
- Alexandre, J.;
- Treluyer, J.-M.;
- Raoul, V.;
- Roché, H.;
- Goldwasser, F.;
- Chatelut, E.
Publication type:
Article
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.
Published in:
2005
By:
- Delord, J. P.;
- Pierga, J. Y.;
- Dieras, V.;
- Bertheault-Cvitkovic, F.;
- Turpin, F. L.;
- Lokiec, F.;
- Lochon, I.;
- Chatelut, E.;
- Canal, P.;
- Guimbaud, R.;
- Mery-Mignard, D.;
- Cornen, X.;
- Mouri, Z.;
- Bugat, R.
Publication type:
journal article
Factors affecting pharmacokinetic variability of oral topotecan: a population analysis.
Published in:
British Journal of Cancer, 2004, v. 90, n. 2, p. 343, doi. 10.1038/sj.bjc.6601469
By:
- Léger, F.;
- Loos, W.J.;
- Fourcade, J.;
- Bugat, R.;
- Goffinet, M.;
- Mathijssen, R.H.J.;
- Verweij, J.;
- Sparreboom, A.;
- Chatelut, E.
Publication type:
Article
CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues.
Published in:
British Journal of Cancer, 1999, v. 80, n. 3/4, p. 364, doi. 10.1038/sj.bjc.6690364
By:
- Guichard, S;
- Terret, C;
- Hennebelle, I;
- Lochon, I;
- Chevreau, P;
- Frétigny, E;
- Selves, J;
- Chatelut, E;
- Bugat, R
Publication type:
Article
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?
Published in:
2017
By:
- Metsu, D.;
- Toutain, P. L.;
- Chatelut, E.;
- Delobel, P.;
- Gandia, P.
Publication type:
journal article

Found: 20